肿瘤坏死因子α诱导蛋白8样分子2在不同肝脏疾病中的免疫调控作用

王闪闪; 张庆山; 赵素贤; 孔令波; 纪雷; 孔丽

doi:10.3969/j.issn.1001-5256.2020.02.050

肿瘤坏死因子α诱导蛋白8样分子2在不同肝脏疾病中的免疫调控作用

DOI: 10.3969/j.issn.1001-5256.2020.02.050

河北医科大学第三医院中西医结合肝病科河北省慢性肝病肝纤维化机制研究重点实验室

基金项目:

河北省卫生厅课题(ZL20140032)；河北省中医药管理局课题(2014142)；

详细信息

中图分类号: R575
计量
- 文章访问数: 848
- HTML全文浏览量: 19
- PDF下载量: 229
- 被引次数: 0
出版历程
- 收稿日期: 2019-09-15
- 出版日期: 2020-02-20

The immunoregulatory effect of tumor necrosis factor-alpha-induced protein 8-like 2 in different liver diseases

Hebei Provincial Key Laboratory for Research on Pathogenesis of Chronic Liver Diseases and Liver Fibrosis,Department of Traditional and Western Medical Hepatology,Third Hospital of Hebei Medical University

Research funding:

摘要

摘要:
肿瘤坏死因子α诱导蛋白8样分子2(TIPE2)可负性调控固有免疫及适应性免疫系统,并通过影响多种信号通路参与肝炎、肝硬化、肝细胞癌等肝脏疾病的发生和发展过程。总结目前TIPE2参与不同肝病发病机制的现有研究,认为TIPE2可能成为治疗不同肝脏疾病的一个新靶点。
- 肝疾病 /
- 肿瘤坏死因子α诱导蛋白8样分子2 /
- 免疫调节
Abstract:
Tumor necrosis factor-alpha-induced protein 8-like 2( TIPE2) can negatively regulate innate immunity and adaptive immunity and participate in the development and progression of various liver diseases,such as hepatitis,liver cirrhosis,and hepatocellular carcinoma,by affecting a variety of signaling pathways. This article summarizes the current research on the involvement of TIPE2 in the pathogenesis of different liver diseases and points out that TIPE2 may become a new target for the treatment of liver diseases.
- liver diseases /
- TIPE2 /
- immunomodulation

HTML全文

参考文献(33)

[1] SUN H,GONG S,CARMODY RJ,et al. TIPE2,a negative regulator of innate and adaptive immunity that maintains immune homeostasis[J]. Cell,2008,133(3):415-426.

[2] ZHANG X,WANG J,FAN C,et al. Crystal structure of TIPE2provides insights into immune homeostasis[J]. Nat Struct Mol Biol,2009,16(1):89-90.

[3] YANG PL,ALTHAGE A,CHUNG J,et al. Immune effectors required for hepatitis B virus clearance[J]. Proc Natl Acad Sci U S A,2010,107(2):798-802.

[4] PHILLIPS S,CHOKSHI S,RIVA A,et al. CD8(+)T cell control of hepatitis B virus replication:Direct comparison between cytolytic and noncytolytic functions[J]. J Immunol,2010,184(1):287-295.

[5] XI W,HU Y,LIU Y,et al. Roles of TIPE2 in hepatitis B virusinduced hepatic inflammation in humans and mice[J]. Mol Immunol,2011,48(9-10):1203-1208.

[6] ZHANG W,ZHANG J,ZHAO L,et al. TIPE2 protein negatively regulates HBV-specific CD8+T lymphocyte functions in humans[J]. Mol Immunol,2015,64(1):204-209.

[7] JIANG LN,ZHANG H,ZHAI JY,et al. TIPE2 and its role in inflammatory diseases[J]. Chin J Immunol,2019,35(19):2410-2413,2418.(in Chinese)蒋丽娜，张红，翟嘉怡，等．TIPE2及其在炎症相关疾病中的作用[J]．中国免疫学杂志，2019,35(19):2410-2413,2418.

[8] FAN Y,ZHANG Y,WANG N,et al. Tumor necrosis factor-α-induced protein 8-like 2(TIPE2)is associated with immune phases of patients with chronic hepatitis B[J]. Oncotarget,2017,8(19):30781-30792.

[9] JI J,ZHANG YY,FAN YC. TIPE2 as a potential therapeutic target in chronic viral hepatitis[J]. Expert Opin Ther Targets,2019,23(6):485-493.

[10] WANG LY,FAN YC,ZHAO J,et al. Elevated expression of tumour necrosis factor-α-induced protein 8(TNFAIP8)-like 2 mRNA in peripheral blood mononuclear cells is associated with disease progression of acute-on-chronic hepatitis B liver failure[J]. J Viral Hepat,2014,21(1):64-73.

[11] FAN YC,WANG N,SUN YY,et al. TIPE2 mRNA level in PBMCs serves as a novel biomarker for predicting short-term mortality of acute-on-chronic hepatitis B liver failure:A prospective single-center study[J]. Medicine(Baltimore),2015,94(39):e1638.

[12] LIN MV,KING LY,CHUNG RT. Hepatitis C virus-associated cancer[J]. Annu Rev Pathol,2015,10:345-370.

[13] KONG L,LIU K,ZHANG YZ,et al. Downregulation of TIPE2mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C[J]. Hepatol Int,2013,7(3):844-849.

[14] MELLOR AL,BABAB B,CHANDLER PR,et al. Cutting edge:CpG oligonucleotides induce splenic CD19+dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling[J]. J Immunol,2005,175(9):5601-5605.

[15] LUAN YY,YAO YM,ZHANG L,et al. Expression of tumor necrosis factor-αinduced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+)regulatory T cells in mice[J]. Mol Immunol,2011,49(1-2):219-226.

[16] KONG L,JIN M,WANG WZ,et al. The mRNA expression of TIPE2,Foxp3,and CTLA-4 in peripheral blood mononucleated cells in patients with chronic hepatitis C and their clinical significance[J]. J Clin Hepatol,2019,35(2):323-327.(in Chinese)孔丽，金萌，王卫真，等．TIPE2、Foxp3、CTLA-4 mRNA在慢性丙型肝炎患者外周血单个核细胞中的表达及临床意义[J]．临床肝胆病杂志，2019,35(2):323-327.

[17] YAO RQ,MA B. The potential role and significance of tumor necrosis factor-αinduced protein 8 like-2 in autoimmune diseases[J]. Med J Chin PLA,2017,42(8):749-752.(in Chinese)姚人骐，马兵．肿瘤坏死因子-α诱导蛋白-8样分子-2在自身免疫疾病中的作用及意义[J]．解放军医学杂志，2017,42(8):749-752.

[18] FREUNDT EC,BIDERE N,LENARDO MJ. A different TIPE of immune homeostasis[J]. Cell,2008,133(3):401-402.

[19] LOU Y,LIU S. The TIPE(TNFAIP8)family in inflammation,immunity,and cancer[J]. Mol Immunol,2011,49(1-2):4-7.

[20] LIU RL,RUAN QG. Advances of negative immune regulator TIPE2 in the pathogenesis of autoimmune diseases[J]. Int J Immunol,2016,39(4):368-372.(in Chinese)刘芮伶，阮庆国．免疫负调控因子TIPE2在自身免疫性疾病发病过程中的作用及机制研究进展[J]．国际免疫学杂志，2016,39(4):368-372.

[21] LI D,TAN Y. TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway[J]. Exp Ther Med,2019,17(4):2937-2944.

[22] QIAN J,MENG Z,GUAN J,et al. Expression and roles of TIPE2 in autoimmune hepatitis[J]. Exp Ther Med,2017,13(3):942-946.

[23] QIN B,WEI T,WANG L,et al. Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Tolllike receptor ligands in primary biliary cirrhosis[J]. J Gastroenterol Hepatol,2016,31(6):1177-1183.

[24] CAI SP,CHENG XY,CHEN PJ,et al. Transmembrane protein88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells[J]. Mol Immunol,2016,80:58-67.

[25] THOMPSON MD,MONGA SP. WNT/beta-catenin signaling in liver health and disease[J]. Hepatology,2007,45(5):1298-1305.

[26] CHENG JH,SHE H,HAN YP,et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis[J]. Am J Physiol Gastrointest Liver Physiol,2008,294(1):g39-g49.

[27] TOKUNAGA Y,OSAWA Y,OHTSUKI T,et al. Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model[J]. Sci Rep,2017,7(1):325.

[28] TUO H,WANG Y,WANG L,et al. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma[J]. Oncotarget,2017,8(39):65687-65698.

[29] XU DD,LI XF,LI YH,et al. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells[J]. Biochem Biophys Res Commun,2018,498(1):199-206.

[30] CAO X,ZHANG L,SHI Y,et al. Human tumor necrosis factor(TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1[J]. Mol Cancer,2013,12(1):149.

[31] ZHANG YH,YAN HQ,WANG F,et al. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2downregulation and NF-κB activation[J]. Int J Oncol,2015,46(1):254-264.

[32] WANG Y,JIANG Y,ZHOU J,et al. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response[J]. Tumour Biol,2016,37(11):15265-15274.

[33] WANG L,CHEN C,FENG S,et al. TIPE-2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3-kinase/AKT signaling pathway[J]. Mol Med Rep,2018,17(5):7017-7026.

施引文献

资源附件(0)

访问统计